Andy Saperstein, the co-president of Morgan Stanley, has been diagnosed with cancer, the executive told employees in an internal memo, The Financial Times’ Joshua Franklin reports. “While my travel may be limited during the period of my treatment, I plan to continue working to make sure Morgan Stanley remains on our great path forward,” he said. Saperstein, who runs Morgan Stanley’s wealth management division, was one of three leading internal candidates to succeed James Gorman as CEO, but it ultimately went to his fellow co-president Ted Pick. Saperstein has agreed to remain at Morgan Stanley under Pick and will also oversee the bank’s investment management business, alongside his role running wealth management.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MS:
- Morgan Stanley Infrastructure Partnres announces investment in UltraEdge
- Morgan Stanley downgraded to Neutral from Outperform at Exane BNP Paribas
- Connecticut announces $6.5M settlement with Morgan Stanley for data security
- Morgan Stanley files automatic mixed securities shelf
- Chegg announces accelerated share repurchase agreement with Morgan Stanley Bank